Literature DB >> 2467768

Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes.

R Misra1, P J Venables, C Plater-Zyberk, P F Watkins, R N Maini.   

Abstract

To elucidate the mechanisms of autoantibody induction in infectious mononucleosis (IM), we have studied sera from 35 patients with IM with enzyme-linked immunosorbent assays using purified antigens. In the IM group 37% had IgM antibodies to cardiolipin above the normal range (mean plus 2 standard deviations of control sera). Significantly elevated frequencies of antibodies to actin (26%) and cytoskeletal antigens (97% versus 29% in normal sera) were also found, but levels of IgM rheumatoid factors, IgM antibodies to single-stranded DNA and antibodies to ribonucleoproteins (nRNP/Sm, Sm and La) were normal. Affinity purified anti-cardiolipin antibodies reacted with the cell membrane of transformed lymphocytes but not with resting cells, suggesting that cell activation was required for the expression of antigenic epitopes. Our data suggest that the autoantibody response in IM is restricted to two classes of autoantigens: cytoskeletal and cell membrane antigens. The appearance of antigenic epitopes on EBV-transformed lymphocytes could be a mechanism for the generation of anti-cardiolipin antibodies in infectious mononucleosis. Similar mechanisms could operate in autoimmune rheumatic disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467768      PMCID: PMC1541872     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Antinuclear factor and other antibodies in blood and liver diseases.

Authors:  E J HOLBOROW; G L ASHERSON; G D JOHNSON; R D BARNES; D S CARMICHAEL
Journal:  Br Med J       Date:  1963-03-09

2.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.

Authors:  A Rosén; P Gergely; M Jondal; G Klein; S Britton
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

3.  Autoantibody to "intermediate filament" in infectious mononucleosis.

Authors:  E Linder; P Kurki; L C Andersson
Journal:  Clin Immunol Immunopathol       Date:  1979-12

4.  Studies on the heterophile antibodies of infectious mononucleosis. I. Separation of four antibody populations, one of which contains lymphocytotoxic activity.

Authors:  J Langhorne; T Feizi
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

5.  Studies on heterophile antigen in lymphoma and leukemia spleens by means of absorption of infectious mononucleosis sera.

Authors:  F Milgrom; K Kano; A Fjelde
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

6.  The occurrence of autoantibodies in infectious mononucleosis.

Authors:  R N Sutton; R T Emond; D B Thomas; D Doniach
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

7.  Antibodies to membrane antigen(s) common to thymocytes and a subpopulation of lymphocytes in infectious-mononucleosis sera.

Authors:  D B Thomas
Journal:  Lancet       Date:  1972-02-19       Impact factor: 79.321

8.  Antinuclear antibodies in infectious mononucleosis.

Authors:  M E Kaplan; E M Tan
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

9.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Authors:  L Slaughter; D A Carson; F C Jensen; T L Holbrook; J H Vaughan
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

2.  Anticardiolipin antibody.

Authors:  A W Joss; M M Steven
Journal:  BMJ       Date:  1990-02-10

3.  Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1.

Authors:  J H Vaughan; J R Valbracht; M D Nguyen; H H Handley; R S Smith; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies.

Authors:  M Sorice; V Pittoni; T Griggi; A Losardo; O Leri; M S Magno; R Misasi; G Valesini
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

5.  Adoptively transferred anti-idiotype pulsed B cells mediate autoimmune myocarditis.

Authors:  R E Paque; R Miller
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum.

Authors:  K H Sun; W T Liu; C Y Tsai; T S Liao; W M Lin; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

7.  Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus.

Authors:  K Xie; M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis.

Authors:  R E Paque; R Miller
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis.

Authors:  C L Yu; K H Sun; C Y Tsai; S R Wang
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

10.  Molecular characterization of virus-induced autoantibody responses.

Authors:  Burkhard Ludewig; Philippe Krebs; Helen Metters; Jutta Tatzel; Ozlem Türeci; Ugur Sahin
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.